PMID: 2108953Mar 1, 1990Paper

Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes

The Journal of Antibiotics
Y SumitaT Okuda

Abstract

We investigated the binding affinities of SM-7338 for penicillin-binding proteins (PBPs) and the morphological changes induced by it compared with those of imipenem. Both SM-7338 and imipenem had the highest binding affinities for PBP-2 of Escherichia coli, which were in good agreement with the primary morphological response of spherical cell formation. SM-7338 also showed high affinities for PBP-1A, -1Bs, and -3, and imipenem showed high affinities for PBP-1A and -1Bs but not for PBP-3. At 4-fold MIC, SM-7338 induced a indeterminate form, whereas imipenem did not. This may be due to the higher affinity of SM-7338 for PBP-3 compared to that of imipenem. Against Pseudomonas aeruginosa, SM-7338 had very high affinities for PBP-2 and -3, and imipenem had higher affinities for PBP-2 and -1A. SM-7338 induced this organism to filamentous cells at a concentration lower than its MIC, bulge cells at 2-fold MIC, and spherical cells at 4-fold MIC, while imipenem principally induced round cell formation at each concentration. These morphological differences in P. aeruginosa may be due to the differences in binding profiles to PBPs. We also studied the affinities for PBPs using radioactive SM-7338. The data obtained supported these results.

Citations

Apr 2, 2002·Expert Opinion on Investigational Drugs·Giovanni BonfiglioGiuseppe Nicoletti
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Yutaka UedaMakoto Sunagawa
Mar 4, 2008·Expert Opinion on Pharmacotherapy·Jomy Joseph, Keith A Rodvold
Dec 28, 2018·The Journal of Antimicrobial Chemotherapy·Shazad MushtaqDavid M Livermore
May 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H HanbergerM Nilsson
Oct 5, 2007·Expert Review of Anti-infective Therapy·Philip D Lister
Oct 6, 2000·Clinical Pharmacokinetics·J W MoutonA A Vinks
Jan 30, 2007·Expert Opinion on Pharmacotherapy·Olaf BurkhardtTobias Welte
Oct 23, 2016·Cellular and Molecular Life Sciences : CMLS·T P Tim CushnieAndrew J Lamb
Feb 1, 1995·Antimicrobial Agents and Chemotherapy·J C Fung-TomcD P Bonner
Jun 1, 1991·Antimicrobial Agents and Chemotherapy·A RaimondiH Nikaido
Jan 1, 1991·Antimicrobial Agents and Chemotherapy·T MaejimaS Mitsuhashi
Apr 1, 1996·Antimicrobial Agents and Chemotherapy·R WhiteJ Bosso
Jun 12, 2019·ACS Chemical Biology·William J GodinezBrian Y Feng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.